August 1, 2012Open Access

Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009

RTRakhshandra TalpurAmgen (United States)LSLotika SinghThe University of Texas MD Anderson Cancer Center SDSeema DaulatThe University of Texas MD Anderson Cancer Center

Key Points

Key points are not available for this paper at this time.

Abstract

Improved outcome of MF/SS, reflected by OS and PFS for all stages, may result from earlier diagnosis, new therapies, and aggressive treatment of infections.

KI fragen

Bookmark

View Full Paper

Cite This Study

Talpur et al. (Wed,) studied this question.

synapsesocial.com/papers/69d7c518f39344339dd181b2 https://doi.org/https://doi.org/10.1158/1078-0432.ccr-12-0604

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal2010 · 848 citations
2Increased Serum Concentration of the Soluble Interleukin-2 Receptor in Cutaneous T-Cell Lymphoma1996 · 88 citations
3Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma2012 · 131 citations
4Total Skin Electron Beam and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Mycosis Fungoides and Sézary Syndrome2010 · 168 citations
5Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)2008 · 978 citations

KI fragen

Bookmark

View Full Paper